Karl-Axel Johansson

Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

Pia Baumann, Jan Nyman, Berit Wennberg et al. · Journal of Clinical Oncology · 2009 · 844 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patients

Jan Nyman, Karl-Axel Johansson, Ulla Hultén · Lung Cancer · 2005 · 248 citations

Medicine, Oncology, Radiation Oncology +9

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries

Pia Baumann, Jan Nyman, Ingmar Lax et al. · Acta Oncologica · 2006 · 224 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose– and volume–response analysis

Niclas Pettersson, Jan Nyman, Karl-Axel Johansson · Radiotherapy and Oncology · 2009 · 170 citations

Medicine, Oncology, Radiation Oncology +17

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

Pia Baumann, Jan Nyman, Giovanna Gagliardi et al. · Radiotherapy and Oncology · 2008 · 143 citations

Medicine, Oncology, Radiation Oncology +15